sulfadiazine has been researched along with Plasma Cell Tumor in 2 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ROBERTSON, T | 1 |
| Abel, G | 1 |
| Connors, TA | 1 |
| Ross, WC | 1 |
| Hoellinger, H | 1 |
| Pichat, L | 1 |
2 other studies available for sulfadiazine and Plasma Cell Tumor
| Article | Year |
|---|---|
Plasmacytosis and hyperglobulinemia as manifestations of hypersensitivity; a postmortem study of two cases with hypersensitivity probably to sulfadiazine.
Topics: Blood Proteins; Drug Hypersensitivity; Humans; Hypersensitivity; Neoplasms; Plasmacytoma; Sulfadiazi | 1950 |
The selective concentration of sulphadiazine and related compounds in malignant tissue.
Topics: Animals; Carbon Isotopes; Carcinoma 256, Walker; Female; Hydrogen-Ion Concentration; Liver; Lymphoma | 1973 |